Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer
暂无分享,去创建一个
J. Minna | A. Gazdar | J. Soh | L. Girard | A. Gazdar | N. Sunaga | Mitsuo Sato | D. Shames | M. Sato | K. Kaira | M. Mori | K. Shimizu | T. Nakano | H. Imai | Y. Iwasaki | K. Shimizu | M. Mori | T. Ishizuka | T. Nakano | Yasuki Iwasaki